2nd Quarter - Report

FABIANI & COMPANY for MEDRAD, INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$40,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 16, 2009 $40,000 Replaced
2nd Quarter - Report Jul 20, 2009 $40,000 Replaced
2nd Quarter - Amendment Oct 15, 2009 $40,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 6331 Medicare Bill- Issues pertaining to physician reimbursement for medical imaging procedures

Foreign entity interest: none

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
JAMES P FABIANI —
ERIN FRY —

Contacted: HOUSE OF REPRESENTATIVES; Natl Aeronautics & Space Administration (NASA); SENATE; Energy, Dept of

Bills named: H.R. 6331 (111th)

Copyright/Patent/Trademark CPT

Patent Reform Act, provisions relating to apportionment of damages

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
JAMES P FABIANI —
ERIN FRY —
WENDY SHELTON —

Contacted: Natl Aeronautics & Space Administration (NASA); Energy, Dept of; SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Department of Commerce, Justice, Science & Related Agencies Appropriations Act of 2009, provisions relating to NASA funding and research; Department of Energy and Water and Related Agencies Appropriations Act of 2010, for medical imaging research

LobbyistCovered position, as disclosed
STEPHEN R CONAFAY —
JAMES P FABIANI —
ERIN FRY —
WENDY SHELTON —

Contacted: SENATE; Energy, Dept of; Natl Aeronautics & Space Administration (NASA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.